Model for Investment and Evaluation of Health Promotion

  • Reinbacher, Gunnar Scott (Projektdeltager)

    Projektdetaljer

    Beskrivelse

    The scope of the project and the model can be divided into a prospective and a retrospective part. The prospective part aims to develop a better methodology for ensuring that the expectations from Health Promotion programmes are fulfilled during the implementation. The retrospective part aims to ensure, that not only programmes with a short financial payback time are evaluated positively, but also systems with a large impact on elements like quality, interpersonal relations, job-motivation/-enhancement and other issues, that are difficult to measure in figures. The focus is the quantitative and the qualitative, the tangible and the intangible elements of compleks Health Promotion. * The prospective part of the model To ensure a successful implementation of Health Promotion it is necessary to make a detailed list of all the expectations of the users from the Health Promotion system. The term user refers to everybody that in some way or another will be using the system. The innovation is, that the model will use the expectations as input to the Benefit Management Process (BMP). The BMP will actively be part of the implementation process. It will focus on the putting in order of priority of the expectations and ensure, that as many as possible of these are fulfilled during the implementation. * The retrospective part of the model In order to carry out a better evaluation of medical systems, the model also focuses on a method, which can be used to show the benefit of the system. The starting point is the expectation analysis to find out, to which degree the expectations have been fulfilled by the implementation. After that the model will be used to analyse the effectiveness using expanded CBA (Cost Benefit Analysis) and CEA (Cost Effectiveness Analysis), and to analyse the efficiency of the system. The analysis of the efficiency will focus on matters that are normally difficult to justify using traditional CBA and CEA. The expanded CBA, the CEA and the CVA will be summarized in the UVA (Utility Value Analysis), and the goal will be a comparison of all the costs and all types of outcome. * Expanded Cost Benefit Analysis (E-CBA), Cost Effectiveness Analysis (CEA) and Cost Value Analysis (CVA) We have extended the project into three analyses: The E-CBA will analyse the costs and benefits in the development and implementation phase of the medical system. The main focus is the medical system and those benefits directly connected to the system. The CEA will also analyse the costs and benefits but focus on the organization's innovative use of the system. The benefits will be more intangible than in the E-CBA and related to a more active use of the system. The CVA will also analyse the cost and benefits obtained from the system, but it will focus on how the system supports the business/scope or goals of the organization. * Utility Value Analysis (UVA) The UVA will summarize the cost and outcome from the E-CBA, CEA and CVA UVA = E-CBA + CEA + CVA The result from this phase can be used as a total view on the investment in and outcome from the Health Promotion system - both in quantitative and qualitative measures. Practical use: The model has been tested during the year 2000 and 2001 to measure effectiveness of Diabetes Management and promotion in different countries in Europe. For 2002 the model will be evaluated and developed as a general model.
    StatusIgangværende
    Effektiv start/slut dato19/05/2010 → …